PROTAI
Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat complex diseases. Protai's platform has made a leap in solving how drug candidates are created and validated, facilitating quicker and more advanced drug discovery.
PROTAI
Social Links:
Industry:
Artificial Intelligence Biotechnology Life Science
Founded:
2021-01-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.protai.bio
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
8 M USD
Current Employees Featured
Founder
Investors List
Pitango Venture Capital
Pitango Venture Capital investment in Seed Round - Protai
Grove Ventures
Grove Ventures investment in Seed Round - Protai
Official Site Inspections
http://www.protai.bio
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Protai"
Protai | Proteomics & AI Drug Discovery
Protai developed a proteomics-centered, vertically integrated platform tailored for drug discovery. Based on a complete disease- and modality-agnostic pipeline; from data collection through …See details»
About Protai
Protai combines deep proteomics with machine learning to accelerate drug discovery and development. AIMSâ„¢ Platform Pipeline COMPANY NEWS Publications We are an AI-powered drug discovery startup that is …See details»
Protai - Crunchbase Company Profile & Funding
Contact Email [email protected] Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat complex diseases. …See details»
Protai Company Profile 2024: Valuation, Funding
Protai General Information Description. Developer of proteomics-centered AI-powered platform designed to improve the way new drugs are discovered. …See details»
Protai - Drug pipelines, Patents, Clinical trials - Synapse
Explore Protai with its drug pipeline, therapeutic area, technology platform, 2 news.See details»
Protai - VentureRadar
"Protai is an AI-powered drug discovery startup aiming to revolutionize the way new drugs can be discovered. The company combine deep proteomics with machine learning to better combat …See details»
Protai raises $8 million in Seed for its proteomics …
Jan 5, 2022 Protai has created what it says is the largest and most diverse proteomic database in the world, with more than 50,000 clinical samples and samples from various organs and indicators. It helps the company establish a …See details»
Protai adds $12 million to Seed round as it aims to …
Mar 15, 2023 Protai, which has developed a proteomics and AI-powered drug discovery platform, announced on Tuesday that it has added $12 million to its Seed round, bringing the total amount to $20 million. The round includes …See details»
With $8M seed round, Protai leverages the proteome to ... - TechCrunch
Jan 5, 2022 Protai co-founders Kirill Pevzner (left) and Eran Seger. Image Credits: Protai The company hopes to be able to span the drug discovery and testing process from tissue testing all the way to final ...See details»
Protai Company Profile - Office Locations, Competitors, Revenue
Protai establishes a baseline to then simulate biological functional processes for a variety of diseases and accelerate drug R&D through clinical and preclinical stages. Type Private Status …See details»
AI drug discovery startup Protai raises $12M in seed funding
Mar 17, 2023 Artificial intelligence (AI)-powered drug discovery startup Protai Bio Ltd. raised $12 million in additional seed funding, bringing the total amount to $20 million that will see the company build out an oncology drug discovery pipeline derived from its AI proteomics platform.See details»
Protai Bio Ltd. - CMOCRO
Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat complex diseases. Protai\'s platform has made a leap in …See details»
Protai – Startups.Bio
Jan 11, 2022 Protai is based in Israel and has raised $8M in seed funding. Subscribe for alerts on new companies featured on Startups.Bio. Type your email… Subscribe November 20, 2024 …See details»
Platform - protai.bio
Leveraging mass spectrometry proteomics and other protein-oriented large scale datasets, we are building machine learning models to identify up to 1,000,000 proteo-forms including post-translational-modifications, protein-protein …See details»
Protai Raises $8 Million Seed Round to Provide a Proteomics …
On January 5, 2022 Protai, an AI-powered drug discovery startup, reported its emergence from stealth, along with an $8 million seed financing round co-led by Grove Ventures and Pitango …See details»
Protai Company Profile Funding & Investors | YourStory
Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the …See details»
Protai Raises Additional $12 Million in Seed Round
Mar 16, 2023 Protai also established collaborations with several leading hospitals, and now has access to over 100k well-defined banked samples for its comprehensive tumor mapping …See details»
Protai - Overview, News & Similar companies | ZoomInfo.com
Mar 14, 2023 View Protai (protai.bio) location in Tel Aviv, Israel , revenue, industry and description. Find related and similar companies as well as employees by title and much more. …See details»
Protai | Scientist.com
Protai.bio: Company Type: New Startup (0-1M TTM Revenue) ... Services Protai, a computational precision oncology company focused on developing predictive proteomics biomarkers to …See details»
Protai Locations - Contract Research Map
4 Ariel Sharon Street Givatayim, 5320047 Israel Protai, a computational precision oncology company focused on developing predictive proteomics biomarkers to enhance drug …See details»